PEDEvidence

SOURCE-LINKED STUDY SUMMARY

Oxymetholone-Associated Cholestatic Drug-Induced Liver Injury With Profound Hyperbilirubinaemia: A Longitudinal Case Report.

Case reports in hepatology ·

Study type unconfirmed

Abstract summarized · Quality not appraised
Studied
A case report of severe bile-flow-related liver injury after self-administered oxymetholone with testosterone enanthate.
Who / model
One 26-year-old man presented after 29 days of oral oxymetholone with intramuscular testosterone enanthate.
Studied dose & schedule
Dose and schedule have not yet been extracted for this summary.
Found
Peak total bilirubin reached 24.6 mg/dL while clotting, albumin and kidney function stayed preserved. After both agents were stopped, bilirubin fell 69.1% by day 57 and 91.5% by day 85, and itching resolved.
Limits
Concomitant testosterone and unverified products prevented definitive attribution to oxymetholone. This uncontrolled case also cannot show that supportive treatment caused recovery.

Read summary source ↗ · Prepared 9/15/2026 · AI-assisted, source-based summary

Research findings apply to the population and conditions studied. This educational summary is not a treatment recommendation or a formal assessment of study quality.

Original publication ↗ · DOI: 10.1155/crhe/2519455

Explore related compounds

How summaries and evidence labels are prepared

← All study summaries